Skip to main content
Clinical Trials/ISRCTN17592092
ISRCTN17592092
Completed
未知

A single-blinded randomised controlled trial exploring the effectiveness of a walking programme and a supervised general exercise programme versus usual physiotherapy for chronic low back pain

Health Research Board (HRB) (Ireland)0 sites246 target enrollmentJanuary 8, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic low back pain
Sponsor
Health Research Board (HRB) (Ireland)
Enrollment
246
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

  1. 2009 protocol in http://www.ncbi.nlm.nih.gov/pubmed/19573247 2. 2015 results in: https://www.ncbi.nlm.nih.gov/pubmed/25599309 (added 21/08/2019)
Registry
who.int
Start Date
January 8, 2009
End Date
October 1, 2010
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Health Research Board (HRB) (Ireland)

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with chronic (greater than or equal to three months) or recurrent (greater than or equal to three episodes in previous 12 months) LBP of mechanical origin with/without radiation to the lower limb
  • 2\. Males/females between 18 \- 65 years
  • 3\. No spinal surgery within the previous 12 months
  • 4\. Patients deemed suitable by their General Practitioner (GP)/hospital consultant to carry out an exercise programme
  • 5\. Patients willing to attend for an 8\-week treatment programme of exercise classes
  • 6\. Access to a telephone (for follow\-up support)
  • 7\. Fluency in English (verbal and written)
  • 8\. Low levels of physical activity measured by the International Physical Activity Questionnaire (IPAQ) (less than 600 MET\-minutes/week)

Exclusion Criteria

  • 1\. Currently or having received treatment for chronic low back pain (CLBP) within previous three months
  • 2\. Red flags indicating serious spinal pathology, e.g. cancer, cauda equina lesion
  • 3\. Radicular pain indicative of nerve root compression
  • 4\. Patients diagnosed with severe spinal stenosis, spondylolisthesis, fibromyalgia
  • 5\. History of systemic/inflammatory disease, e.g. rheumatoid arthritis
  • 6\. Patients with any confounding conditions such as a neurological disorder or currently receiving treatment for cancer
  • 7\. Patients with acute (less than six weeks) or subacute LBP (6 \- 12 weeks), provided that they have experienced less than three LBP episodes during previous 12 months
  • 8\. Unstable angina/uncontrolled cardiac dysrhythmias/severe aortic stenosis/acute systemic infection accompanied by fever
  • 9\. Medico\-legal issues

Outcomes

Primary Outcomes

Not specified

Similar Trials